The sigma-1 receptor-TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis

Abstract

Background: Therapy in the latent period is favorable for retarding the process of epileptogenesis. Recently, we have discovered that the activated sigma-1 receptor (Sig-1R) attenuates the hippocampus pathological injury and memory impairment in the latent period of epileptogenesis. But the molecular mechanism needs further investigation.

Methods: PRE-084 was utilized as a research tool to highly selectively activate Sig-1R in epileptic mice. After the treatment of PRE-084, the pro-inflammatory cytokines, neuropathological traits, and the level of mitochondrial translocator assembly and maintenance 41 homolog (TAMM41) in the hippocampus were examined. The mode in which the Sig-1R interacts with TAMM41 was explored. The role of TAMM41 in the protecting effect of PRE-084 was established.

Results: PRE-084 inhibited the growth of pro-inflammatory cytokines, reduced the formation of gliosis, alleviated neuronal damage in the hippocampus, and attenuated memory impairment in the latent period of epileptogenesis. The protein level of TAMM41 decreased in the hippocampi of epileptic mice and increased in the PRE-084-treated mice. The Sig-1R bound with TAMM41 directly, maintaining the stability of TAMM41. Knockdown of TAMM41 reversed the protective effect of PRE-084, and overexpression of TAMM41 exhibited a similar protective action to that of PRE-084.

Conclusion: We presented the concept of the “sigma-1 receptor-TAMM41 axis” and proposed that augmenting this axis can attenuate neuroinflammation and memory impairment in the process of epileptogenesis.

Keywords

epileptogenesis / memory impairment / mitochondrial translocator assembly and maintenance 41 homolog / neuroinflammation / sigma-1 receptor

References

[1] Becker AJ. Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol. 2018;44(1):112-129.

[2] Ohgomori T, Jinno S. Modulation of neuropathology and cognitive deficits by lipopolysaccharide preconditioning in a mouse pilocarpine model of status epilepticus. Neuropharmacology. 2020;176:108227.

[3] Li G, Bauer S, Nowak M, et al. Cytokines and epilepsy. Seizure. 2011;20(3):249-256.

[4] Peng W, Shen Y, Wang Q, Ding J, Wang X. TPPU pre-treatment rescues dendritic spine loss and alleviates depressive behaviours during the latent period in the lithium chloride-pilocarpine-induced status epilepticus rat model. Brain Sci. 2021;11(11):1465.

[5] Su TP, Su TC, Nakamura Y, Tsai SY. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci. 2016;37(4):262-278.

[6] Szabo A, Kovacs A, Riba J, Djurovic S, Rajnavolgyi E, Frecska E. The endogenous hallucinogen and trace amine N, N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells. Front Neurosci. 2016;10:423.

[7] Motawe ZY, Abdelmaboud SS, Cuevas J, Breslin JW. PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation. Int J Biochem Cell Biol. 2020;126:105803.

[8] Vavers E, Zvejniece L, Maurice T, Dambrova M. Allosteric modulators of Sigma-1 receptor: a review. Front Pharmacol. 2019;10:223.

[9] Guo L, Gao T, Jia X, et al. SKF83959 attenuates memory impairment and depressive-like behavior during the latent period of epilepsy via allosteric activation of the Sigma-1 receptor. ACS Chem Nerosci. 2022;13(22):3198-3209.

[10] Tamura Y, Harada Y, Yamano K, et al. Identification of Tam41 maintaining integrity of the TIM23 protein translocator complex in mitochondria. J Cell Biol. 2006;174(5):631-637.

[11] Blunsom NJ, Gomez-Espinosa E, Ashlin TG, Cockcroft S. Mitochondrial CDP-diacylglycerol synthase activity is due to the peripheral protein, TAMM41 and not due to the integral membrane protein, CDP-diacylglycerol synthase 1. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(3):284-298.

[12] Yang RM, Tao J, Zhan M, et al. TAMM41 is required for heart valve differentiation via regulation of PINK-PARK2 dependent mitophagy. Cell Death Differ. 2019;26(11):2430-2446.

[13] Zhang X, Farrell JJ, Tong T, et al. Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer’s disease. Alzheimers Dement. 2021;18:294-306.

[14] Swan EJ, Maxwell AP, McKnight AJ. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes. Diabet Med. 2015;32(8):1110-1115.

[15] Wang Y, Ni J, Gao T, Gao C, Guo L, Yin X. Activation of astrocytic sigma-1 receptor exerts antidepressant-like effect via facilitating CD38-driven mitochondria transfer. Glia. 2020;68(11):2415-2426.

[16] Tse K, Puttachary S, Beamer E, Sills GJ, Thippeswamy T. Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studies. PLoS ONE. 2014;9(5):e96622.

[17] McLin JP, Steward O. Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains. Eur J Neurosci. 2006;24(8):2191-2202.

[18] Guo L, Chen Y, Zhao R, et al. Allosteric modulation of sigma-1 receptors elicits anti-seizure activities. Br J Pharmacol. 2015;172(16):4052-4065.

[19] Guo L, Gao T, Gao C, et al. Stimulation of astrocytic sigma-1 receptor is sufficient to ameliorate inflammation-induced depression. Behav Brain Res. 2021;410:113344.

[20] Wang Y, Gao C, Gao T, Zhao L, Zhu S, Guo L. Plasma exosomes from depression ameliorate inflammation-induced depressive-like behaviors via sigma-1 receptor delivery. Brain Behav Immun. 2021;94:225-234.

[21] Lee PT, Lievens JC, Wang SM, et al. Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nat Commun. 2020;11(1):5580.

[22] Long Q, Upadhya D, Hattiangady B, et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. Proc Natl Acad Sci USA. 2017;114(17):E3536-E3545.

[23] Puttachary S, Sharma S, Thippeswamy A, Thippeswamy T. Immediate epileptogenesis: impact on brain in C57BL/6J mouse kainate model. Front Biosci (Elite Ed). 2016;8(3):390-411.

[24] Ballough GP, Martin LJ, Cann FJ, et al. Microtubule-associated protein 2 (MAP-2):a sensitive marker of seizure-related brain damage. J Neurosci Methods. 1995;61(1–2):23-32.

[25] Suleymanova EM. Behavioral comorbidities of epilepsy and neuroinflammation: evidence from experimental and clinical studies. Epilepsy Behav. 2021;117:107869.

[26] Jiang C, Caskurlu A, Ganesh T, Dingledine R. Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation. Brain Behav Immun Health. 2020;8:100132.

[27] Verhoog QP, Holtman L, Aronica E, van Vliet EA. Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis. Front Neurol. 2020;11:591690.

[28] Gao T, Gao C, Liu Z, et al. Inhibition of noncanonical Ca²⁺ oscillation/calcineurin/GSK-3β pathway contributes to anti-inflammatory effect of sigma-1 receptor activation. Neurochem Res. 2022;47(2):264-278.

[29] Motawe ZY, Farsaei F, Abdelmaboud SS, Cuevas J, Breslin JW. Sigma-1 receptor activation-induced glycolytic ATP production and endothelial barrier enhancement. Microcirculation. 2020;27(6):e12620.

[30] Jerram AH, Smith PF, Darlington CL. The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behaviour, locomotor activity and ataxia in Guinea pig. Eur J Pharmacol. 1996;307(3):269-273.

[31] Chou YC, Liao JF, Chang WY, Lin MF, Chen CF. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 1999;821(2):516-519.

[32] Skuza G, Rogoz Z. Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL/6J mice. Pharmacol Rep. 2009;61(6):1179-1183.

RIGHTS & PERMISSIONS

2023 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.